In an ovarian cancer model, treatment with estrogen also downregulated P-gp protein without amplification of ABCB1; however, they found that treatment with progesterone did increase ABCB1 RNA, and a combination treatment of estrogen and progesterone led to lower ABCB1 RNA and P-gp levels [123]. This evidence concerns the gene PGP and ovarian cancer.